Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
about
Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersStroke, dementia, and drug deliveryA systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.An herbal nasal drop enhanced frontal and anterior cingulate cortex activityThe association of diabetes and dementia and possible implications for nondiabetic populations.Is nose-to-brain transport of drugs in man a reality?Crosstalk between metabolic and neuropsychiatric disordersHelping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.Role of insulin metabolism disturbances in the development of Alzheimer disease: mini review.Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.Intranasal delivery of therapeutic proteins for neurological diseases.A Precision Medicine Approach to Oxytocin Trials.Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.Insulin increases excitability via a dose-dependent dual inhibition of voltage-activated K+ currents in differentiated N1E-115 neuroblastoma cells.Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans.Nose-to-brain delivery of tacrine.Obese men respond to cognitive but not to catabolic brain insulin signaling.From nose to brain: understanding transport capacity and transport rate of drugs
P2860
Q24562763-D2EF9029-9048-4E01-9672-7E5164272361Q28166505-DAF1E2A8-14B8-418D-9008-D0A5C442E2B1Q34396290-E6C3CFEE-D4FF-498B-9B75-F32EB4059164Q35117046-DCB0D79D-7248-4604-A10C-A8740DCE71A6Q35619553-91D0A1AD-A341-49DA-B153-587EB1D3A8DFQ35673938-62C64D8A-7B02-4E7B-8564-2E7674FE68FCQ36073458-FF4992A6-3ECD-4DBE-8749-0F9D1AE74B28Q36685572-A2275495-B6D6-4348-BA59-B8BE084F9D03Q37058255-561E1A57-FE90-440A-B4D9-0E1FED04429BQ37416147-1B052A05-5228-48CD-8ECA-F65C844D08F9Q37689883-808C66B1-F474-4E44-B558-E8211E652623Q37880893-463A7A30-F049-4673-AE1E-4C05A5388598Q38641885-EBE96B7D-E109-4B0C-A4DE-0F2A1263D38FQ39013294-910C345E-763B-46E0-8DF5-C07D515DAC52Q39991976-F6AA6FA9-DEE9-4521-B42D-E9BEF5B5A817Q44688158-BA62449D-43F2-4AA7-A5A4-0A6D090C8673Q46990286-8B816564-0B01-41E9-A0E3-A66277C458F9Q50888528-51787E38-DFC8-49E7-B73F-4B40078F5839Q56893840-920FAAC5-0F44-4AE4-8F18-0FF82067BA0F
P2860
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@ast
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@en
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@nl
type
label
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@ast
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@en
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@nl
prefLabel
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@ast
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@en
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@nl
P2093
P1476
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
@en
P2093
P356
10.1016/S0014-2999(00)00540-9
P407
P577
2000-09-01T00:00:00Z